Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

NCT06718946 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

BIOLOGICAL: IDOV-SAFE

Sponsor

Fudan University